← Back to headlines
United Therapeutics Board Approves $2B Share Repurchase, Prices $1.5B ASR
United Therapeutics' board of directors has approved a new $2 billion share repurchase authorization and priced a $1.5 billion accelerated share repurchase (ASR) program.
9 Mar, 11:37 — 9 Mar, 11:37
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Former Budget Secretary Amenah Pangandaman Appointed Head of Amanah Islamic Bank
just now
Ebonyi CSOs threaten legal action against EEDC over alleged overbilling, disconnections
11m ago
NIMASA urged to use 3% levy for indigenous operators' loans
17m ago